Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Hunninghake

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Metabolism: Clinical and Experimental|August 1, 1983
Alterations in human serum alkaline phosphatase and its isoenzymes by hypolipidemic agents: colestipol and clofibrateJ L Probstfield, B E Statland, L Gorman, et al.
The American Journal of Clinical Nutrition|December 1, 1990
Cholesterol-lowering effects of soluble-fiber cereals as part of a prudent diet for patients with mild to moderate hypercholesterolemiaL P Bell, K J Hectorn, H Reynolds, et al.
Metabolism: Clinical and Experimental|January 1, 1985
Carotenoids and vitamin A: the effect of hypocholesterolemic agents on serum levelsJ L Probstfield, T L Lin, J Peters, et al.
Circulation|December 1, 1982
Recruitment from clinical studiesD B Hunninghake, F Peterson, M LaDouceur, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Effect of cholestyramine and colestipol on the absorption of phenytoinJ T Callaghan, M Tsuru, J L Holtzman, et al.
Atherosclerosis|April 1, 1991
Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humansJ N Yuan, M Y Tsai, J Hegland, et al.
Health Education Research|May 8, 1992
Evaluation of implementation of a cholesterol management program in physicians' officesK Glanz, M Brekke, D Harper, et al.
Clinical Pharmacology and Therapeutics|September 1, 1985
Controlled trial of acifran in type II hyperlipoproteinemiaD B Hunninghake, K D Edwards, G S Sopko, et al.
Metabolism: Clinical and Experimental|October 1, 1985
Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemiaB J Hoogwerf, J R Peters, I D Frantz, et al.
Annals of Surgery|July 1, 1979
Sensitivity of the canine pancreatic intraductal pressure to subclinical reduction in cholinesterase acitivityT D Dressel, R L Goodale, D B Hunninghake, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Metabolism: Clinical and Experimental|August 1, 1983
Alterations in human serum alkaline phosphatase and its isoenzymes by hypolipidemic agents: colestipol and clofibrateJ L Probstfield, B E Statland, L Gorman, et al.
The American Journal of Clinical Nutrition|December 1, 1990
Cholesterol-lowering effects of soluble-fiber cereals as part of a prudent diet for patients with mild to moderate hypercholesterolemiaL P Bell, K J Hectorn, H Reynolds, et al.
Metabolism: Clinical and Experimental|January 1, 1985
Carotenoids and vitamin A: the effect of hypocholesterolemic agents on serum levelsJ L Probstfield, T L Lin, J Peters, et al.
Circulation|December 1, 1982
Recruitment from clinical studiesD B Hunninghake, F Peterson, M LaDouceur, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Effect of cholestyramine and colestipol on the absorption of phenytoinJ T Callaghan, M Tsuru, J L Holtzman, et al.
Atherosclerosis|April 1, 1991
Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humansJ N Yuan, M Y Tsai, J Hegland, et al.
Health Education Research|May 8, 1992
Evaluation of implementation of a cholesterol management program in physicians' officesK Glanz, M Brekke, D Harper, et al.
Clinical Pharmacology and Therapeutics|September 1, 1985
Controlled trial of acifran in type II hyperlipoproteinemiaD B Hunninghake, K D Edwards, G S Sopko, et al.
Metabolism: Clinical and Experimental|October 1, 1985
Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemiaB J Hoogwerf, J R Peters, I D Frantz, et al.
Annals of Surgery|July 1, 1979
Sensitivity of the canine pancreatic intraductal pressure to subclinical reduction in cholinesterase acitivityT D Dressel, R L Goodale, D B Hunninghake, et al.
Pageof 12